4 draws · 43 markers
Bloodwork
Every panel from January through March 2026. Full numeric values. No reference-range abstraction. The whole point is to see what actually happened to my hormones, lipids, and liver markers across the cycle.
Trend across draws
| Marker | 1/8 (Baseline) | 2/3 (Mid-SARM) | 3/2 (Post-SARM) | 3/24 (On-Cycle) | Trend |
|---|---|---|---|---|---|
| AST | 51 ⚠️ | 42 ⚠️ | — | 35 ✅ | ↓ Improving |
| ALT | 30 | 33 | — | 30 | → Stable |
| Marker | 1/8 (Baseline) | 2/3 (Mid-SARM) | 3/2 (Post-SARM) | 3/24 (On-Cycle) | Trend |
| -------- | ---------------- | ----------------- | ------------------ | ------------------ | ------- |
| Total Chol | 145 | 132 | — | 167 | ↑ Rising (still normal) |
| TG | 67 | 41 | — | 63 | → Near baseline |
| HDL | 55 | 66 | — | 69 ✅ | ↑ All-time high |
| LDL | 77 | 56 | — | 86 | ↑ Rebounding (optimal) |
| Marker | 1/8 (Baseline) | 3/2 (Post-SARM) | Next Check | ||
| -------- | ---------------- | ------------------ | ------------ | ||
| Total T | 1,073 | 1,152 | Wk 4-6 (~Apr 10-24) | ||
| Free T | 130.9 | 240.8 | Wk 4-6 | ||
| LH | 3.6 | 5.2 | Wk 4-6 (will be suppressed on Test C) | ||
| FSH | 2.77 | 4.06 | Wk 4-6 (will be suppressed on Test C) | ||
| E2 | 27 | 58 ⚠️ | Wk 4-6 (E2 sensitive) | ||
| SHBG | 55 | 28 | Wk 4-6 | ||
| Marker | 1/8 (Baseline) | Next Check | |||
| -------- | ---------------- | ------------ | |||
| Hematocrit | 48.9% ⚠️ | Wk 4-6 — critical on Test C | |||
| Hemoglobin | 16.2 | Wk 4-6 | |||
| RBC | 5.13 | Wk 4-6 | |||
| Marker | Warning | Action | Stop | ||
| -------- | --------- | -------- | ------ | ||
| Hematocrit | >52% → phlebotomy | >54% → STOP ALL | >54% | ||
| HDL | <42 → warn | <38 → halve Test C | <35 → stop Test C + Accutane | ||
| ALT | >3× ULN (~165) → concerns | >5× ULN (~275) → stop Accutane | >5× ULN | ||
| AST | >3× ULN (~123) → concerns | Monitor | — | ||
| TG | >300 → escalate omega-3 | >400 → stop Accutane (pancreatitis) | >500 | ||
| E2 | No AI unless symptomatic | If needed: Adex 0.25mg pin days | Never crash below 20 | ||
| CK | >1,000 → warn | >5,000 → ER | >5,000 | ||
| Threshold | Current Value | Buffer | Risk Level | ||
| ----------- | --------------- | -------- | ------------ | ||
| HDL <42 (warn) | 69 | 27 points | 🟢 Low | ||
| HDL <35 (stop) | 69 | 34 points | 🟢 Low | ||
| ALT >165 (3× ULN) | 30 | 135 points | 🟢 Low | ||
| TG >300 | 63 | 237 points | 🟢 Low | ||
| Hct >52% (phlebotomy) | 48.9 (baseline) | 3.1 points | 🟡 Monitor | ||
| Hct >54% (stop all) | 48.9 (baseline) | 5.1 points | 🟡 Monitor | ||
| Timing | Date Range | Panel | Critical Markers | ||
| -------- | ------------ | ------- | ------------------ | ||
| On-cycle bloods | ~Apr 10-24 (Wk 4-6) | Comprehensive | CBC (Hct!), lipids, liver, TT/FT/E2 sensitive, Hct, DHT | ||
| End of cycle | ~May 8 | Optional | Lipids + CBC if Hct was borderline at wk 4-6 | ||
| Post-cycle | ~June 2026 | Recovery | Full hormones, lipids, CBC, liver |